1B). Therefore, the ginsenoside Rg3-enriched fraction obtained from DIAION HP20 column of the crude ginseng extract contained 80–90 mg/g freeze-dried powder. This yield corresponded to an ∼80 times greater concentration of ginsenoside Rg3 determined in the crude ginseng extract. Nevertheless, as shown in Fig. 1B, ginseol k-g3 also contained other ginsenosides such as Rk1 and Rg5 in the following compositions: 41.68 mg/g and 75.04 mg/g, respectively. The effects of single and repeated treatment of ginseol k-g3 at various doses (12.5 mg/kg, 25 mg/kg, 50 mg/kg, 100 mg/kg and 200 mg/kg) on locomotor activity of mice were examined. The effects

of RG (100 mg/kg), Rg3 (20 mg/kg and 40 mg/kg) and donezepil (5 mg/kg) were also evaluated for comparison. As shown in Fig. 2A, DAPT nmr single treatment with the four doses of ginseol k-g3 did not affect locomotor activity of mice (p > 0.05). Furthermore, ginseol k-g3 did not affect rearing frequency of mice (p > 0.05, Fig. 2B). It was also notable that RG, the two doses of Rg3, as well as the single dose of donezepil did not alter ambulatory and stereotypic behaviors of mice ( Fig. 2A and B). Meanwhile, no differential locomotor activities were observed in both saline- and ginseol k-g3-treated mice during Day3 and Day 6 of drug administration. As selleck kinase inhibitor shown in Fig. 2C, the total moved distance and rearing frequency ( Fig. 2D) were similar between control

and ginseol k-g3-treated mice, and also in mice treated with RG and Rg3. Altogether, these results indicate that ginseol k-g3 does not cause sedation upon single or repeated administration. These findings also demonstrate that ginseol k-g3 does not impair motor function or exploratory activity. Spontaneous alternation behavior determined using the Y-maze test has been viewed as an indicator of spatial

short-term memory [34]. In this test, mice must remember the arm most recently entered in order to alternate arm choice. Furthermore, treatment with scopolamine has been demonstrated to impair spontaneous alternation behavior in animal models [21]. As shown in Fig. 3A, spontaneous alternation behavior in scopolamine-treated mice was significantly lower than in mice treated with vehicle (p < 0.01). DOK2 One-way ANOVA showed lack of effect of all doses of ginseol k-g3 in improving scopolamine-induced reduction of spontaneous alternation in mice (p > 0.05). RG and the two doses of Rg3 also failed to enhance spontaneous alternation behavior in scopolamine-treated mice. In contrast, donezepil significantly reversed the cognitive deficit induced by scopolamine in the Y-maze task [t (18) = 4.71, p < 0.001]. Together, these results suggest that that ginseol k-g3, RG and Rg3 do not influence short-term or working memory. Meanwhile, as shown in Fig. 3B, no significant differences were observed among experimental groups in the number of arm entries. This result corroborates the observation that ginseol k-g3 does not affect general locomotor activity of mice.